Targeted Therapies in Leukemia
Järås Group Our ResearchAcute myeloid leukemia (AML) is a fatal disorder of the blood-forming bone marrow cells. The cellular origin of AML is thought to be a normal hematopoietic stem cell that through a series of genetic lesions gives rise to cells with leukemia-initiating capacity, also termed leukemia stem cells (LSCs), which propagate into frank AML. The major goals of our research is to iden
https://www.stemcellcenter.lu.se/research-groups/jaras - 2025-04-29